neuroClues

The company develops a portable, CE-marked Class IIa medical device that uses high-speed infrared cameras and AI algorithms to record and analyze eye movement biomarkers. This platform is designed for neurologists and clinicians to support the differential diagnosis of parkinsonian syndromes, cerebellar impairment, and other neurological disorders. The system provides objective, quantified data and video recordings to help monitor disease progression and inform treatment decisions in clinical practice.